Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Peptides × Breast × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 6 Gastrointestinal 2 Tumor-Agnostic 1 CNS 1 Breast 1

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Cyclophosphamide 422 Trastuzumab 408 Paclitaxel 374 Docetaxel 313 Capecitabine 265 Letrozole 261 Carboplatin 257 Doxorubicin 213 Tamoxifen 183 Epirubicin 176 Fulvestrant 174 Radiotherapy 170 Anastrozole 163 pembrolizumab 151 Surveys and Questionnaires 144 pertuzumab 141 Exercise 141 exemestane 127 Vinorelbine 127 palbociclib 124 Bevacizumab 123 Magnetic Resonance Spectroscopy 119 Blood Specimen Collection 118 Drug Therapy 105 Albumin-Bound Paclitaxel 105 Gemcitabine 99 130-nm albumin-bound paclitaxel 98 eribulin 90 pyrotinib 89 Biopsy 87

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06195618 2025-06-25

TEBICA003 TNBC

Universidad Nacional de Colombia

Phase 1 Not yet recruiting

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡